We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.38B
AUM Growth
+$750M
Cap. Flow
+$1.01B
Cap. Flow %
29.86%
Top 10 Hldgs %
27.81%
Holding
544
New
135
Increased
136
Reduced
128
Closed
73

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$389M
2
MSFT icon
Microsoft
MSFT
+$95.1M
3
AAPL icon
Apple
AAPL
+$51.5M
4
MAS icon
Masco
MAS
+$45.7M
5
MCD icon
McDonald's
MCD
+$42.3M

Top Sells

Rank Stock Value
1
FFIV icon
F5
FFIV
+$49M
2
MSCI icon
MSCI
MSCI
+$30.2M
3
PPC icon
Pilgrim's Pride
PPC
+$29.4M
4
DOX icon
Amdocs
DOX
+$22.9M
5
ANSS
Ansys
ANSS
+$21.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.08%
2 Healthcare 18.13%
3 Technology 17.51%
4 Industrials 12.07%
5 Consumer Staples 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
501
Tvardi Therapeutics
TVRD
$22M
– –
-3,170
Closed -$1.63M
VOXX
502
DELISTED
VOXX International Corporation Class A
VOXX
– –
-12,260
Closed -$91K
CDMO
503
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-124,360
Closed -$888K
TRVN
504
DELISTED
Trevena, Inc.
TRVN
– –
-165
Closed -$1.07M
FRTX
505
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
– –
-302
Closed -$438K
INFI
506
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-74,770
Closed -$632K
MTEM
507
DELISTED
Molecular Templates, Inc.
MTEM
– –
-811
Closed -$545K
CLVS
508
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-8,030
Closed -$738K
SAFM
509
DELISTED
Sanderson Farms Inc
SAFM
– –
-225
Closed -$15K
NP
510
DELISTED
Neenah, Inc. Common Stock
NP
– –
-445
Closed -$26K
ADXS
511
DELISTED
Advaxis Inc
ADXS
– –
-4,068
Closed -$624K
ADMS
512
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-65,640
Closed -$1.1M
PFNX
513
DELISTED
Pfenex Inc.
PFNX
– –
-31,910
Closed -$479K
MNTA
514
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-55,100
Closed -$904K
LABL
515
DELISTED
Multi-Color Corp
LABL
– –
-340
Closed -$26K
GNCA
516
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-12,984
Closed -$712K
AET
517
DELISTED
Aetna Inc
AET
– –
-75,150
Closed -$8.22M
PAY
518
DELISTED
Verifone Systems Inc
PAY
– –
-760,600
Closed -$21.1M
RPXC
519
DELISTED
RPX Corporation
RPXC
– –
-55,000
Closed -$755K
TESO
520
DELISTED
Tesco Corp
TESO
– –
-123,340
Closed -$881K
SCLN
521
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
– –
-12,140
Closed -$84K
MACK
522
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-8,278
Closed -$554K
JNS
523
DELISTED
Janus Capital Group Inc
JNS
– –
-204,030
Closed -$2.77M
QLTI
524
DELISTED
QLT Inc
QLTI
– –
-26,260
Closed -$70K
RSTI
525
DELISTED
Rofin-Sinar Technologies Inc
RSTI
– –
-23,180
Closed -$601K
18 19 20
21
22

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Smith Group Asset Management held 544 positions worth $3.38B, up 28% from $2.63B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Smith Group Asset Management deployed $1.01B of net new capital in Q4 2015, opening 135 new positions and adding to 136 existing holdings. Its largest new stake was Masco: 1,605,910 shares worth $45.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Lockheed Martin, an estimated $15.9M trimmed.

  • Smith Group Asset Management's largest Q4 2015 buy was Masco: 1,605,910 shares worth $45.4M.
  • Smith Group Asset Management added most to Allergan plc in Q4 2015, an estimated $389M increase.
  • Smith Group Asset Management's biggest Q4 2015 reduction was Lockheed Martin, cutting an estimated $15.9M.
  • Smith Group Asset Management fully exited F5 in Q4 2015, selling an estimated $49M.
  • Smith Group Asset Management's ten largest holdings make up 28% of its $3.38B portfolio in Q4 2015.
  • Smith Group Asset Management opened 135 new positions and closed 73 in Q4 2015.
  • Smith Group Asset Management's portfolio value rose 28% quarter-over-quarter to $3.38B.

Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.